HOME >> BIOLOGY >> NEWS
JCI table of contents: April 12, 2007

EDITOR'S PICK: Two heads are better than one: two dysfunctional DNA repair pathways kill tumor cells

Individuals who inherit two mutant copies of any one of about 12 genes that make the proteins of the Fanconi Anemia (FA) pathway develop FA, which is characterized by increased incidence of cancer and bone marrow failure, among other things. However, individuals with just a single mutant copy of one of these genes are also at increased risk of developing cancer. This occurs when the remaining "good" copy of the gene becomes mutated in a specific cell type, allowing that cell type to form a tumor. However, hope of a new treatment for these cancers has now been provided by researchers from the Dana-Farber Cancer Institute in Boston who suggest that inhibiting the protein ATM might kill these cancer cells.

In the study, which appears online on April 12 in advance of publication in the May print issue of the Journal of Clinical Investigation, Alan D'Andrea and colleagues show that loss of ATM function in human cell lines with a dysfunctional FA pathway caused the cells to die. The dying cells were characterized by high levels of DNA breakage, which is consistent with the fact that FA pathway proteins and ATM are important regulators of two distinct DNA repair pathways. It therefore seems that the ATM pathway of DNA repair keeps the FA pathwaydeficient tumor cells alive and that loss of this pathway results in tumor cell death. As FA pathwaydeficient tumor cells were shown to be sensitive to an inhibitor of ATM, the authors suggest that ATM might provide a therapeutic target for the treatment of individuals with FA pathwaydeficient tumors.

TITLE: Fanconi anemia pathwaydeficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated

AUTHOR CONTACT:
Alan D. D'Andrea
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Phone: (617) 632-2112; Fax: (617) 63
'"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
12-Apr-2007


Page: 1 2 3 4 5 6

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2019)... ... February 26, 2019 , ... ... In her position as Account Manager, Ms. Baptiste demonstrated her ability to advocate ... experience. Ms. Baptiste was responsible for partnering with both the Strategic Development team ...
(Date:2/22/2019)... ... February 21, 2019 , ... Clean label food is ... when creating natural foods and beverages. It is quite common to spot consumers running ... meat products are not immune to this label scrutiny. , More than ever, ...
(Date:2/22/2019)... ... February 21, 2019 , ... The ... executed a research agreement establishing a collaborative program to work toward applications of ... develop new radiopharmaceutical lead candidates and will explore Fuzionaire Dx’s platform as a ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... 14, 2019 , ... Open registration for the Case Management ... of Case Management,” continues as CMSA makes plans to host the annual event ... management industry conference serving the educational and networking needs of case and care ...
(Date:3/14/2019)... (PRWEB) , ... March 13, 2019 , ... ... its 2019 ISPE Europe Biotechnology Conference , taking place in Brussels, Belgium ... biotechnology best practices, technical and operational solutions, and innovative approaches. , “Biopharmaceuticals ...
(Date:3/12/2019)... (PRWEB) , ... March 12, 2019 , ... ... preparation and epigenetics research, has launched its third generation long-fragment DNA shearing innovation, ... generation instrument with a user-friendly interface, automated processing, and the ability to ...
(Date:3/9/2019)... ... March 07, 2019 , ... ACEA Biosciences ... development and commercialization of high performance, cutting-edge cell analysis platforms for life science ... GLP-certified expertise in cardiovascular pharmacology and electrophysiology, are announcing a partnership to provide ...
Breaking Biology Technology:
Cached News: